MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 26, 2005; DOI: 10.1124/mol.105.011833


0026-895X/05/6801-251-259$20.00
Mol Pharmacol 68:251-259, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.011833v1
68/1/251    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujino, H.
Right arrow Articles by Regan, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujino, H.
Right arrow Articles by Regan, J. W.

Differential Regulation of Phosphorylation of the cAMP Response Element-Binding Protein after Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2

Hiromichi Fujino, Sambhitab Salvi, and John W. Regan

Department of Pharmacology and Toxicology, College of Pharmacy, the University of Arizona, Tucson, Arizona

The EP2 and EP4 prostanoid receptors are G-protein-coupled receptors whose activation by their endogenous ligand, prostaglandin (PG) E2, stimulates the formation of intracellular cAMP. We have previously reported that the stimulation of cAMP formation in EP4-expressing cells is significantly less than in EP2-expressing cells, despite nearly identical levels of receptor expression (J Biol Chem 277:2614–2619, 2002). In addition, a component of EP4 receptor signaling, but not of EP2 receptor signaling, was found to involve the activation of phosphatidylinositol 3-kinase (PI3K). In this study, we report that PGE2 stimulation of cells expressing either the EP2 or EP4 receptor results in the phosphorylation of the cAMP response element binding protein (CREB) at serine-133. Pretreatment of cells with N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline (H-89), an inhibitor of protein kinase A (PKA), attenuated the PGE2-mediated phosphorylation of CREB in EP2-expressing cells, but not in EP4-expressing cells. Pretreatment of cells with wortmannin, an inhibitor of PI3K, had no effects on the PGE2-mediated phosphorylation of CREB in either EP2- or EP4-expressing cells, although it significantly increased the PGE2-mediated activation of PKA in EP4-expressing cells. However, combined pretreatment with H-89 and wortmannin blocked PGE2-mediated phosphorylation in EP2-expressing cells as well as in EP2-expressing cells. PGE2-mediated intracellular cAMP formation was not affected by pretreatment with wortmannin, or combined treatment with wortmannin and H-89, in either the EP2- or EP4-expressing cells. These findings suggest that PGE2 stimulation of EP4 receptors, but not EP2 receptors, results in the activation of a PI3K signaling pathway that inhibits the activity of PKA and that the PGE2-mediated phosphorylation of CREB by these receptors occurs through different signaling pathways.


Received February 4, 2005; accepted April 18, 2005

Address correspondence to: Dr. John W. Regan, Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721–0207. E-mail: regan{at}pharmacy.arizona.edu




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. M. Sturm, P. Schratl, R. Schuligoi, V. Konya, G. J. Sturm, I. Th. Lippe, B. A. Peskar, and A. Heinemann
Prostaglandin E2 Inhibits Eosinophil Trafficking through E-Prostanoid 2 Receptors
J. Immunol., November 15, 2008; 181(10): 7273 - 7283.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Khayrullina, J.-H. Yen, H. Jing, and D. Ganea
In Vitro Differentiation of Dendritic Cells in the Presence of Prostaglandin E2 Alters the IL-12/IL-23 Balance and Promotes Differentiation of Th17 Cells
J. Immunol., July 1, 2008; 181(1): 721 - 735.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. M. Ansari, J. E. Rundhaug, and S. M. Fischer
Multiple Signaling Pathways Are Responsible for Prostaglandin E2-Induced Murine Keratinocyte Proliferation
Mol. Cancer Res., June 1, 2008; 6(6): 1003 - 1016.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-H. Yen, T. Khayrullina, and D. Ganea
PGE2-induced metalloproteinase-9 is essential for dendritic cell migration
Blood, January 1, 2008; 111(1): 260 - 270.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L.-K. Sun, T. Reding, M. Bain, M. Heikenwalder, D. Bimmler, and R. Graf
Prostaglandin E2 modulates TNF-{alpha}-induced MCP-1 synthesis in pancreatic acinar cells in a PKA-dependent manner
Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1196 - G1204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Elberg, D. Elberg, T. V. Lewis, S. Guruswamy, L. Chen, C. J. Logan, M. D. Chan, and M. A. Turman
EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1622 - F1632.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. M. Ansari, Y. M. Sung, G. He, and S. M. Fischer
Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin
Carcinogenesis, October 1, 2007; 28(10): 2063 - 2068.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Donnini, F. Finetti, R. Solito, E. Terzuoli, A. Sacchetti, L. Morbidelli, P. Patrignani, and M. Ziche
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways
FASEB J, August 1, 2007; 21(10): 2418 - 2430.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Rao, R. Redha, I. Macias-Perez, Y. Su, C. Hao, R. Zent, M. D. Breyer, and A. Pozzi
Prostaglandin E2-EP4 Receptor Promotes Endothelial Cell Migration via ERK Activation and Angiogenesis in Vivo
J. Biol. Chem., June 8, 2007; 282(23): 16959 - 16968.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
Z Cheng, E L Sheldrick, E Marshall, D C Wathes, D R E Abayasekara, and A P F Flint
Control of cyclic AMP concentration in bovine endometrial stromal cells by arachidonic acid
Reproduction, May 1, 2007; 133(5): 1017 - 1026.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Huang, S. H. Wettlaufer, C. Hogaboam, D. M. Aronoff, and M. Peters-Golden
Prostaglandin E2 inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L405 - L413.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Murakami, H. Kohsaka, H. Kitasato, and T. Akahoshi
Lipopolysaccharide-Induced Up-Regulation of Triggering Receptor Expressed on Myeloid Cells-1 Expression on Macrophages Is Regulated by Endogenous Prostaglandin E2
J. Immunol., January 15, 2007; 178(2): 1144 - 1150.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Yang, Y. Huang, R. Porta, K. Yanagisawa, A. Gonzalez, E. Segi, D. H. Johnson, S. Narumiya, and D. P. Carbone
Host and Direct Antitumor Effects and Profound Reduction in Tumor Metastasis with Selective EP4 Receptor Antagonism
Cancer Res., October 1, 2006; 66(19): 9665 - 9672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-Y. Qian, A. Leung, P. Harding, and M. C. LaPointe
PGE2 stimulates human brain natriuretic peptide expression via EP4 and p42/44 MAPK
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1740 - H1746.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Fujino and J. W. Regan
EP4 Prostanoid Receptor Coupling to a Pertussis Toxin-Sensitive Inhibitory G Protein
Mol. Pharmacol., January 1, 2006; 69(1): 5 - 10.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics